Trials / Recruiting
RecruitingNCT07112937
The Effect of Multimodal Treatment of Rectal Cancer on Circulating Tumor Cells: A Prospective, Observational Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- The Institute of Molecular and Translational Medicine, Czech Republic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The prospective study will focus on patients undergoing multimodal treatment for rectal cancer. The main objective of the study will be to monitor changes in circulating tumor cells (CTCs) in the peripheral blood of patients during multimodal treatment. For each patient enrolled in the study, peripheral blood samples will be collected at specified time intervals to determine the presence and quantity of CTCs. The CTCs levels will be compared among rectal cancer patients with neoadjuvant chemoradiotherapy and without neoadjuvant chemotherapy.
Conditions
Timeline
- Start date
- 2023-05-02
- Primary completion
- 2026-12-31
- Completion
- 2027-12-31
- First posted
- 2025-08-08
- Last updated
- 2025-08-08
Locations
1 site across 1 country: Czechia
Source: ClinicalTrials.gov record NCT07112937. Inclusion in this directory is not an endorsement.